Ignite Creation Date:
2025-12-24 @ 7:34 PM
Ignite Modification Date:
2026-02-23 @ 1:10 AM
Study NCT ID:
NCT01869803
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2018-03-02
First Post:
2013-05-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia
Sponsor:
Organization: